2021 American Transplant Congress

TOPIC: Clinical Science » Kidney » Kidney Immunosuppression: Novel Regimens and Drug Minimization

Evaluation of a Weight-Based Mycophenolate Mofetil Dosing Protocol for Kidney Transplant Maintenance Immunosuppression
M. Mahoney¹, E. Kincaide¹, J. Nelson¹, K. Klein¹, R. Hall¹, S. Bhayana²
Evaluation of Conversion to Extended-Release Tacrolimus in Abdominal Organ and Thoracic Transplant Recipients
A. Diamond¹, N. Agarwal², A. Younas², N. Sifontis², J. Au¹, C. Ruggia-Check¹
Evaluation of Empiric Extended-Release Tacrolimus Dosing in Adult Kidney Transplant Recipients
C. Patel, S. Lee, D. M. Salerno, N. W. Lange, J. Hedvat
Evaluation of Rituximab-abbs in Renal Transplant: A Case Series
A. Dao¹, B. Jimenez², A. Reyad¹, J. Guiteau¹, M. Madhrira³, N. Umezurike¹, S. Patel¹, S. Allam³
Immunosuppression and Cancer Risk in Kidney Transplant Recipients: A Retrospective Cohort Study
R. Sapir-Pichhadze¹, C. Laprise¹, X. Zhang¹, M. Abrahamowicz¹, M. Beauchamp², A. Della Vecchia¹, L. Azoulay¹, E. Franco¹, B. Nicolau¹
Kidney Transplant Outcomes Stratified by Age with a Calcineurin and Steroid Free Regimen
R. Scalzo¹, M. Harris¹, J. Morris², J. Byrns¹
Kidney Transplant Outcomes Stratified by Race with a Calcineurin and Steroid Free Regimen
R. E. Scalzo, M. T. Harris, J. D. Morris, J. S. Byrns
Modeling of Alternative Weight-Based Dosing Strategies of LCP-Tacrolimus in De Novo Kidney Transplant Patients
J. D. Momper¹, S. J. Patel², M. A. Moten², D. R. Stevens², U. Meier-Kriesche²
Obesity Impacts Acute Rejection but Not Allograft Function Improvement in the Setting of Belatacept Conversion
D. Pierce, J. Benken, P. West-Thielke, I. Tzvetanov, E. Benedetti, A. Lichvar
Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss
R. Valero¹, A. Aguilera¹, E. Rodrigo¹, D. San Segundo², M. Lopez-Hoyos², J. Ruiz¹